Symbotic Inc. (SYM) closed out its fiscal year with the kind of quarter that makes analysts reach for their calculators to bump up price targets. The warehouse automation company didn't just meet expectations—it beat them while quietly expanding into an entirely new industry.

The Numbers Tell a Good Story

Fourth-quarter revenue came in at $618 million, representing 10% year-over-year growth and topping the Street's $604 million estimate. But the real headline was margin expansion. Adjusted EBITDA reached $49.4 million, with adjusted gross margins hitting 22.1% compared to the consensus expectation of 20.8%. That margin improvement was driven by strong performance in the Systems segment.

Needham analyst James Ricchiuti liked what he saw enough to maintain his Buy rating and raise his price target from $57 to $70. His reasoning? The company's new storage structure should provide additional margin tailwinds while opening up fresh market opportunities through improved density and faster installation times.

Breaking Into Healthcare

Perhaps the most interesting development was Symbotic adding Medline as its first customer in the healthcare market. This marks a significant expansion beyond the company's traditional retail and distribution center clientele, suggesting the technology has broader applications than initially thought.

Looking Ahead

Management's fiscal first-quarter guidance came in ahead of expectations on both lines. The company projects revenue of $610 million to $630 million and adjusted EBITDA of $49 million to $53 million. The midpoints of both ranges beat consensus estimates of $611.5 million and $50.8 million, respectively.

Investors clearly appreciated the results. Shares jumped 39.12% to $77.15, pushing the stock near the upper end of its 52-week range of $16.31 to $84.00. With a market cap of $8.59 billion, Symbotic has established itself as a meaningful player in the machinery and industrials sector, riding the wave of interest in automation and supply chain solutions.